newsfilter
← Latest News
GlobeNewswire·

Kaleido Biosciences to Participate in the Jefferies Virtual Next Generation IBD Therapeutics Summit

LEXINGTON, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (NASDAQ:KLDO), a clinical-stage biotech company with a differentiated, small-molecule approach to treating inflammatory conditions and diseases by selectively targeting the r